Related Experiment Videos
Treatment of benign nodular thyroid disease
1Department of Endocrinology, University Hospital Nijmegen, The Netherlands.
The New England Journal of Medicine
|May 15, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
European journal of endocrinology·2018
Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors.
Journal of endocrinological investigation·2017
Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.
Clinical pharmacology and therapeutics·2017
Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.
The Journal of clinical endocrinology and metabolism·2012
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
The Journal of clinical endocrinology and metabolism·2012
Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries.
The New England journal of medicine·2026
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
[Analysis of clinicopathological and immunological characteristics of patients with acquired immune deficiency syndrome-associated diffuse large B-cell lymphoma complicated by Talaromyces marneffei infection].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026